Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) just unveiled an update.
Jacobio Pharmaceuticals Group Co., Ltd. announced changes in the interests of parties acting in concert, with voting rights decreasing from approximately 26.67% to 25.21% due to the departure of certain individuals. Despite this change, the company remains committed to its business strategy and long-term development plan, with the largest shareholder group maintaining its position. Departed individuals have expressed confidence in the company’s long-term value by voluntarily agreeing to a one-year lock-up on their shares, indicating stability and trust in the company’s future.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on developing innovative medical solutions and is listed on the Hong Kong Stock Exchange under the stock code 1167.
YTD Price Performance: 192.13%
Average Trading Volume: 8,138,386
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.94B
Find detailed analytics on 1167 stock on TipRanks’ Stock Analysis page.